Efficacy of intraoperative intravenous lidocaine for postoperative analgesia following bariatric surgery: a meta-analysis of randomized controlled studies

doi:10.1016/j.soard.2021.08.014

Chia Nan University of Pharmacy & Science Institutional Repository > 中心級單位 > 通識教育中心 > 期刊論文 > Item 310902800/34312

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34312

標題:	Efficacy of intraoperative intravenous lidocaine for postoperative analgesia following bariatric surgery: a meta-analysis of randomized controlled studies
作者:	Hung, Kuo-Chuan Chang, Ying-Jen Chen, I-Wen Chang, Yang-Pei Chiu, Sheng-Fu Sun, Cheuk-Kwan
貢獻者:	Chi Mei Med Ctr, Dept Anesthesiol Chia Nan Univ Pharm & Sci, Gen Educ Ctr Chia Nan Univ Pharm & Sci,Dept Recreat & Hlth Care Management Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Neurol Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol Chi Mei Hosp, Dept Oral & Maxillofacial Surg E Da Hosp, Dept Emergency Med I Shou Univ, Coll Med
關鍵字:	Laparoscopic bariatric surgery Lidocaine Opioid Quality of recovery
日期:	2021
上傳時間:	2023-11-11 11:42:43 (UTC+8)
出版者:	ELSEVIER SCIENCE INC
摘要:	Background: The impact of intravenous lidocaine in adults undergoing laparoscopic bariatric sur-geries (LBS) remains unclear. Objectives: This study aimed at investigating the effect of intravenous lidocaine on postoperative opioid consumption and recovery following LBS. Setting: Meta-analysis. Methods: We searched databases including MEDLINE, Embase, Google Scholar, and the Cochrane Library for randomized controlled trials that evaluated the use of intravenous lidocaine compared to placebo only prior to May 2021. The primary outcome was 24-hour postoperative opioid consump-tion, while secondary outcomes included pain score, quality of recovery (QOR)-40 score, length of hospital stay (LOS), and postoperative nausea/vomiting (PONV). Results: Seven trials (496 participants) were included. Intraoperative intravenous lidocaine signif-icantly reduced 24-hour equivalent morphine consumption (mean difference [MD]: -11.97 mg; 95% confidence interval [CI]: -23.12 to -.83), pain score at 1 to 3 hours (MD: -.77; 95% CI: -1.5 to -.04), and LOS (MD: -8.93 hr; 95% CI: -13.41 to -4.44) without positive impact on 24-hour pain score and PONV. There was also an increase in time to first opioid requirement (MD: 20.23 min; 95% CI: 11.76-28.7) and QOR-40 score (MD: 24.38; 95% CI: 5.57-43.18). How-ever, sensitivity analysis demonstrated evidence supporting the beneficial effect of lidocaine only for time to first opioid requirement and QOR-40. The associations of intraoperative intravenous lidocaine with reductions in morphine consumption, pain score at 1 to 3 hours, and LOS after LBS were also weak. Conclusion: Intraoperative intravenous lidocaine during LBS prolonged time to first opioid require-ment and improved quality of recovery postoperatively without 24-hour pain or nausea/vomiting benefits. Due to the small number of trials, larger studies are warranted to verify our findings. (C) 2021 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
關聯:	SURG OBES RELAT DIS, v.18, n.1, pp.135-147
显示于类别:	[通識教育中心] 期刊論文 [休閒保健管理系(所)] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	169	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....